Organoid: Bridging the gap between basic research and clinical practice

被引:7
|
作者
Weng, Guihu [1 ]
Tao, Jinxin [1 ]
Liu, Yueze [1 ]
Qiu, Jiangdong [1 ]
Su, Dan [1 ]
Wang, Ruobing [1 ]
Luo, Wenhao [1 ]
Zhang, Taiping [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan,Wangfujing St, Beijing 100730, Peoples R China
关键词
Organoid; Tumor biology; Microbes-host interaction; Regenerative strategy; Clinical decision-making; New generation of organoid platform; PANCREATIC-CANCER ORGANOIDS; PATIENT-DERIVED ORGANOIDS; STEM-CELLS; IN-VITRO; INTESTINAL ORGANOIDS; MODEL; GENOME; ASSAY; CLASSIFICATION; HETEROGENEITY;
D O I
10.1016/j.canlet.2023.216353
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nowadays, the diagnosis and treatment system of malignant tumors has increasingly tended to be more precise and personalized while the existing tumor models are still unable to fully meet the needs of clinical practice. Notably, the emerging organoid platform has been proven to have huge potential in the field of basic translational medicine, which is expected to promote a paradigm shift in personalized medicine. Here, given the unique advantages of organoid platform, we mainly explore the prominent role of organoid models in basic research and clinical practice from perspectives of tumor biology, tumorigenic microbes-host interaction, clinical decision-making, and regenerative strategy. In addition, we also put forward some practical suggestions on how to construct a new generation of organoid platform, which is destined to vigorously promote the reform of basic translational medicine.
引用
收藏
页数:18
相关论文
共 50 条